Novo’s CagriSema shows 25% weight loss in women
Novo on Tuesday said its next-generation obesity drug, CagriSema, showed 25% weight loss on average among adult women in a...
HEALTH & FITNESS
Sickle cell gene therapies offer new hope, accessing them is hard
This microscope photo provided on Oct. 25, 2023, by the Centers for Disease Control and Prevention shows crescent-shaped red blood...
Here’s our monthly update on our 32 stocks, including 2 more names to buy
What a week to have a Monthly Meeting. On Thursday, Jim Cramer and portfolio director Jeff Marks held our October...
Cancer vaccine manufacturing time could shrink
Merck CEO Rob Davis told CNBC on Wednesday that he expects the company's breakthrough cancer vaccine with Moderna to get faster...
What a mom and CEO tells her kids every day amid all the AI cheating
CNBC is now accepting nominations for the 2027 Changemakers List.Kate Ryder has no doubts about the extent to which AI...
UnitedHealth Group (UNH) earnings Q3 2026
UnitedHealth Group signage on the floor of the New York Stock Exchange on April 21, 2025.Michael Nagle | Bloomberg |...
Why we like Starbucks’ latest turnaround move — plus, two more wins for Eli Lilly
Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just in time...
Micron drops despite ‘a great quarter.’ Why Cramer is sticking with the stock
Every weekday, the CNBC Investing Club with Jim Cramer holds a "Morning Meeting" livestream at 10:20 a.m. ET. Here's a...
Starbucks tells me Chipotle takeover won’t happen and that’s good for the stock
Every weekday, the CNBC Investing Club with Jim Cramer holds a "Morning Meeting" livestream at 10:20 a.m. ET. Here's a...
Bank earnings, ASML and TSMC
CNBC's Jim Cramer on Friday said the start of earnings season next week will give investors a clearer picture of...
For final 10% of cystic fibrosis patients, breakthrough hasn’t come
Emily Kramer-Golinkoff founded Emily's Entourage in 2011 to speed up research for the final 10% of CF patients.Emily's EntourageFor the...
Trump doesn’t think Russia plague incident is bioweapon, plans Putin call
US President Donald Trump speaks about "Trump accounts," investment savings accounts for children, in the Oval Office in the White...
Trump set to talk to Russia’s Putin ‘very soon’ about plague-related death in Siberia
US President Donald Trump speaks to members of the media on the South Lawn of the White House after arriving...
Cramer on Galleri FDA approval
Key PointsCNBC's Jim Cramer said Tuesday that shares of healthcare company Grail can go higher.Investors have been growing increasingly optimistic...
Trump offers U.S. help to Russia after plague death; WHO assesses the situation as low risk
U.S. President Donald Trump speaks to press members before boarding Marine One on the South Lawn of the White House...
AstraZeneca CEO says Summit drug could drive future cancer combos
AstraZeneca CEO Pascal Soriot told CNBC on Monday that Summit Therapeutics' lead drug could help power next-generation cancer treatment combinations...
Russian lab worker dies amid plague reports — here’s what we know
A researcher at a Russian anti-plague institute has died of what's been identified as a case of the plague, according...
BioMarin reports five-year Pompe disease data
Piotr Swat | Lightrocket | Getty ImagesOn Friday, BioMarin announced five-year data from a Phase 3 trial for the drugs...
Russia hospitalizes almost 200 people after plague death: reports
A giant Russian national flag flies behind apartment blocks in Saint Petersburg, Russia Feb. 19, 2025. Anton Vaganov | ReutersNearly 200...
Novartis signs $7.8 billion Abogen biotech licensing deal
Novartis has signed a deal worth up to $7.8 billion, in the latest of a flurry of tie-ups between Big...
